1. Preoperative evolocumab combined with rosuvastatin did not significantly reduce six-month major adverse cardiovascular events but improved several clinically relevant ...
Management of Dyspnea With High-Flow Nasal Air or Fan-A Randomized Controlled Crossover Trial 1. In patients with advanced cancer who ...
1. In this multi-database retrospective cohort study, rosuvastatin was found to be associated with slightly decreased risk of all-cause mortality ...
1. 27.1% of patient in the statin group reported muscle pain and weakness compared to 26.6% in the control groups. ...
1. 3-year composite outcome of stroke and cardiovascular disease was comparable between both groups (9.1% combination vs. 9.9% monotherapy). 2. ...
1. This study showed that the net benefit of statins compared to risk varied considerably with respect to the age ...
1. In patients with average LDL cholesterol levels and elevated CRP, rosuvastatin significantly reduced the risk of a first major ...
